rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Greenland Mines Ltd

GRML · Nasdaq

Health CareBiotechnologyNot moving yetLongevity Biotech

GRML stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 55.0% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 52
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$931K
Insider sales, 12 months
$114K
Officials’ trades on record
0
Institutions holding
45 (+21)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$632KNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months4
Sale orders, 12 months2
Buyers · sellers3 · 1
WhoDidSharesTraded
Riad Hussein El-DadaOthersold3,500at $9.351 Oct 2026filed 5 Oct 2026
Jeff LeblancChief Financial Officerbought14,000at $9.7225 Aug 2026filed 25 Aug 2026
Jason David SawyerDirectorbought240,000at $0.233122 Jul 2026filed 23 Jul 2026
Jon McGarityDirectorbought140,000at $0.177320 Jul 2026filed 20 Jul 2026
Jeff LeblancChief Financial Officerbought1,400,000at $0.175216 Jul 2026filed 17 Jul 2026
Riad Hussein El-DadaDirectorsold175,000at $0.231725 Jun 2026filed 26 Jun 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders45+21 on the quarter
New · exited24 · 3
Reported value$4.9M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Meteora Capital, LLCunchanged · filed 14 Aug 20265,373,755$1.4M00.0%
CITADEL ADVISORS LLCnew · filed 14 Aug 20265,165,648$1.3M+5,165,648
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20263,038,347$790K+2,461,071+426.3%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 20261,027,209$267K+286,749+38.7%
Davidson Kempner Capital Management LPnew · filed 14 Aug 20261,000,000$260K+1,000,000
VANGUARD FIDUCIARY TRUST COadded · filed 13 Aug 2026641,720$167K+270,017+72.6%
RENAISSANCE TECHNOLOGIES LLCnew · filed 13 Aug 2026457,086$119K+457,086
STATE STREET CORPadded · filed 7 Aug 2026302,500$79K+106,100+54.0%
UBS Group AGreduced · filed 13 Aug 2026264,263$69K-808,735−75.4%
NORTHERN TRUST CORPadded · filed 13 Aug 2026247,380$64K+169,439+217.4%
30 Sep 2024 – 30 Jun 2026
82644Sep 24Mar 25Sep 25Dec 25Jun 26

News

Everyone who traded it

Riad Hussein El-Dada Company insiderOther · last 1 Oct 20260 · 2
Jeff LeBlanc Company insiderChief Financial Officer · last 25 Aug 20262 · 0
Jason David Sawyer Company insiderDirector · last 22 Jul 20261 · 0
Jon McGarity Company insiderDirector · last 20 Jul 20261 · 0
Joseph Sinkule Company insiderChief Executive Officer · last 4 Mar 20260 · 0
Samuel M. Zentman Company insiderDirector · last 4 Mar 20260 · 0
Shalom Hirschman Company insiderDirector · last 4 Mar 20260 · 0
Steven Urbach Company insider10% owner · last 2 Jul 20240 · 3
Redwoods Capital Llc Company insider10% owner · last 7 Apr 20222 · 0

Same industry

MRNA ModernaLeading+147%
ENTX Entera BioLeading+37%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2025 · to 31 Dec 2025-75.1%
Share count trendFY 2025 · to 31 Mar 202667.1%
Cash and equivalentsFY 2025 · to 31 Dec 2025$7.2M

Analyst forecasts

No analyst forecasts yet.